{"id":26398,"date":"2024-08-12T15:03:17","date_gmt":"2024-08-12T22:03:17","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=26398"},"modified":"2025-06-04T15:44:49","modified_gmt":"2025-06-04T22:44:49","slug":"ivig-for-b-cell-chronic-lymphocytic-leukemia-cll","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/","title":{"rendered":"IVIG cho b\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u00e3n t\u00ednh t\u1ebf b\u00e0o B (CLL)"},"content":{"rendered":"<p><a href=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig\/\/ivig\/\">Globulin mi\u1ec5n d\u1ecbch ti\u00eam t\u0129nh m\u1ea1ch (IVIG)<\/a> li\u1ec7u ph\u00e1p thay th\u1ebf l\u00e0 m\u1ed9t bi\u1ec7n ph\u00e1p h\u1ed7 tr\u1ee3 m\u00e0 m\u1ed9t s\u1ed1 b\u00e1c s\u0129 k\u00ea \u0111\u01a1n cho b\u1ec7nh nh\u00e2n m\u1eafc b\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u00e3n t\u00ednh t\u1ebf b\u00e0o B (CLL) khi h\u1ecd c\u00f3 <a href=\"https:\/\/ameripharmaspecialty.com\/vi\/other-health-conditions\/hypogammaglobulinemia\/\">h\u1ea1 gammaglobulin m\u00e1u<\/a> (n\u1ed3ng \u0111\u1ed9 huy\u1ebft thanh th\u1ea5p c\u1ee7a t\u1ea5t c\u1ea3 c\u00e1c kh\u00e1ng th\u1ec3, ch\u1eb3ng h\u1ea1n nh\u01b0 IgG, IgM v\u00e0 IgA) ho\u1eb7c c\u00f3 nguy c\u01a1 cao b\u1ecb nhi\u1ec5m tr\u00f9ng t\u00e1i ph\u00e1t th\u01b0\u1eddng xuy\u00ean.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-5a6eaf88ab894dce3201a7e38a230901\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tNh\u1eadn h\u1ed7 tr\u1ee3 \u0111\u1ed3ng thanh to\u00e1n IVIG\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>B\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u00e3n t\u00ednh t\u1ebf b\u00e0o B (CLL) l\u00e0 m\u1ed9t lo\u1ea1i ung th\u01b0 m\u00e1u \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn t\u1ebf b\u00e0o lympho B, lo\u1ea1i t\u1ebf b\u00e0o b\u1ea1ch c\u1ea7u (WBC) s\u1ea3n xu\u1ea5t kh\u00e1ng th\u1ec3 \u0111\u1ec3 ch\u1ed1ng l\u1ea1i nhi\u1ec5m tr\u00f9ng.&nbsp;&nbsp;<\/p>\n\n\n\n<p>Tuy nhi\u00ean, b\u1ec7nh nh\u00e2n m\u1eafc b\u1ec7nh CLL t\u1ebf b\u00e0o B kh\u00f4ng s\u1ea3n xu\u1ea5t \u0111\u01b0\u1ee3c kh\u00e1ng th\u1ec3 c\u00f3 ch\u1ee9c n\u0103ng, l\u00e0m suy y\u1ebfu h\u1ec7 th\u1ed1ng mi\u1ec5n d\u1ecbch v\u00e0 khi\u1ebfn h\u1ecd d\u1ec5 b\u1ecb nhi\u1ec5m vi-r\u00fat ho\u1eb7c vi khu\u1ea9n.&nbsp;<\/p>\n\n\n\n<p>B\u00e0i vi\u1ebft n\u00e0y th\u1ea3o lu\u1eadn ng\u1eafn g\u1ecdn v\u1ec1 b\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u00e3n t\u00ednh t\u1ebf b\u00e0o B, c\u00e1ch IVIG c\u00f3 th\u1ec3 gi\u00fap b\u1ec7nh nh\u00e2n m\u1eafc b\u1ec7nh n\u00e0y v\u00e0 nh\u1eefng g\u00ec <a href=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig\/\/ivig-brand-reviews\/\">C\u00e1c th\u01b0\u01a1ng hi\u1ec7u IVIG<\/a> c\u00f3 s\u1eb5n cho t\u00ecnh tr\u1ea1ng CLL t\u1ebf b\u00e0o B.&nbsp;<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Chuy\u1ec3n \u0111\u1ed5i m\u1ee5c l\u1ee5c\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Chuy\u1ec3n \u0111\u1ed5i<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/#What_Is_B-Cell_Chronic_Lymphocytic_Leukemia_CLL\" >B\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u00e3n t\u00ednh t\u1ebf b\u00e0o B (CLL) l\u00e0 g\u00ec?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/#Role_of_IVIG_in_B-Cell_Chronic_Lymphocytic_Leukemia_CLL\" >Vai tr\u00f2 c\u1ee7a IVIG trong b\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u00e3n t\u00ednh t\u1ebf b\u00e0o B (CLL)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/#How_Does_IVIG_Work\" >IVIG ho\u1ea1t \u0111\u1ed9ng nh\u01b0 th\u1ebf n\u00e0o?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/#Is_There_Any_Specific_Brand_of_IVIG_Available_for_B-Cell_Chronic_Lymphocytic_Leukemia_CLL_Patients\" >C\u00f3 lo\u1ea1i IVIG n\u00e0o d\u00e0nh ri\u00eang cho b\u1ec7nh nh\u00e2n m\u1eafc b\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u00e3n t\u00ednh t\u1ebf b\u00e0o B (CLL) kh\u00f4ng?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/#Do_All_B-Cell_Chronic_Lymphocytic_Leukemia_CLL_Patients_Require_IVIG_Therapy\" >C\u00f3 ph\u1ea3i t\u1ea5t c\u1ea3 b\u1ec7nh nh\u00e2n m\u1eafc b\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u00e3n t\u00ednh t\u1ebf b\u00e0o B (CLL) \u0111\u1ec1u c\u1ea7n \u0111i\u1ec1u tr\u1ecb b\u1eb1ng IVIG kh\u00f4ng?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/#Summary\" >B\u1ea3n t\u00f3m t\u1eaft<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-what-is-b-cell-chronic-lymphocytic-leukemia-cll\"><span class=\"ez-toc-section\" id=\"What_Is_B-Cell_Chronic_Lymphocytic_Leukemia_CLL\"><\/span><strong>B\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u00e3n t\u00ednh t\u1ebf b\u00e0o B (CLL) l\u00e0 g\u00ec?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>B\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u00e3n t\u00ednh t\u1ebf b\u00e0o B (CLL) l\u00e0 m\u1ed9t trong nh\u1eefng lo\u1ea1i ung th\u01b0 m\u00e1u ph\u1ed5 bi\u1ebfn nh\u1ea5t, ph\u00e1t sinh khi t\u1ebf b\u00e0o B ung th\u01b0 t\u0103ng sinh v\u1edbi t\u1ed1c \u0111\u1ed9 kh\u00f4ng mong mu\u1ed1n v\u00e0 t\u0103ng s\u1ed1 l\u01b0\u1ee3ng theo th\u1eddi gian.&nbsp;<\/p>\n\n\n\n<p>Th\u00f4ng th\u01b0\u1eddng, \u1edf ng\u01b0\u1eddi kh\u1ecfe m\u1ea1nh, t\u1ebf b\u00e0o g\u1ed1c lymphoid bi\u1ec7t h\u00f3a th\u00e0nh t\u1ebf b\u00e0o lympho B tr\u01b0\u1edfng th\u00e0nh ho\u1ea1t \u0111\u1ed9ng, gi\u00fap t\u0103ng c\u01b0\u1eddng h\u1ec7 mi\u1ec5n d\u1ecbch v\u00e0 ch\u1ed1ng nhi\u1ec5m tr\u00f9ng. Tuy nhi\u00ean, \u1edf ng\u01b0\u1eddi m\u1eafc b\u1ec7nh b\u1ea1ch c\u1ea7u lymphoblastic d\u00f2ng lympho B (CLL), t\u1ebf b\u00e0o g\u1ed1c lymphoid \u0111\u1ed9t bi\u1ebfn bi\u1ec7t h\u00f3a th\u00e0nh t\u1ebf b\u00e0o B b\u1ea5t th\u01b0\u1eddng, ti\u1ebfp t\u1ee5c ph\u00e2n chia v\u00e0 b\u1eaft \u0111\u1ea7u t\u00edch t\u1ee5 trong t\u1ee7y x\u01b0\u01a1ng, m\u00e1u, h\u1ea1ch b\u1ea1ch huy\u1ebft, l\u00e1ch v\u00e0 gan.&nbsp;<\/p>\n\n\n\n<p>Nh\u1eefng t\u1ebf b\u00e0o lympho B b\u1ea5t th\u01b0\u1eddng n\u00e0y tr\u00f4ng gi\u1ed1ng nh\u01b0 t\u1ebf b\u00e0o B tr\u01b0\u1edfng th\u00e0nh nh\u01b0ng kh\u00f4ng c\u00f3 ch\u1ee9c n\u0103ng v\u00e0 k\u00e9m hi\u1ec7u qu\u1ea3 trong vi\u1ec7c ch\u1ed1ng l\u1ea1i nhi\u1ec5m tr\u00f9ng do s\u1ea3n xu\u1ea5t kh\u00e1ng th\u1ec3 b\u1ecb suy gi\u1ea3m.&nbsp;<\/p>\n\n\n\n<p>H\u01a1n n\u1eefa, kh\u00f4ng gi\u1ed1ng nh\u01b0 c\u00e1c t\u1ebf b\u00e0o b\u00ecnh th\u01b0\u1eddng, c\u00e1c t\u1ebf b\u00e0o lympho B b\u1ea5t th\u01b0\u1eddng kh\u00f4ng tr\u1ea3i qua <a href=\"https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/apoptosis\">qu\u00e1 tr\u00ecnh ch\u1ebft r\u1ee5ng t\u1ebf b\u00e0o<\/a> (m\u1ed9t qu\u00e1 tr\u00ecnh ch\u1ebft t\u1ebf b\u00e0o t\u1ef1 nhi\u00ean). Do \u0111\u00f3, m\u1ed9t l\u01b0\u1ee3ng l\u1edbn t\u1ebf b\u00e0o B b\u1ea5t th\u01b0\u1eddng s\u1ebd chi\u1ebfm ch\u1ed7 trong t\u1ee7y x\u01b0\u01a1ng v\u00e0 c\u1ea3n tr\u1edf qu\u00e1 tr\u00ecnh s\u1ea3n xu\u1ea5t c\u00e1c t\u1ebf b\u00e0o m\u00e1u kh\u1ecfe m\u1ea1nh, ch\u1eb3ng h\u1ea1n nh\u01b0 h\u1ed3ng c\u1ea7u (RBC), ti\u1ec3u c\u1ea7u v\u00e0 b\u1ea1ch c\u1ea7u.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-role-of-ivig-in-b-cell-chronic-lymphocytic-leukemia-cll\"><span class=\"ez-toc-section\" id=\"Role_of_IVIG_in_B-Cell_Chronic_Lymphocytic_Leukemia_CLL\"><\/span><strong>Vai tr\u00f2 c\u1ee7a IVIG trong b\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u00e3n t\u00ednh t\u1ebf b\u00e0o B (CLL)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>B\u1ec7nh nh\u00e2n m\u1eafc b\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u1ea1n t\u00ednh t\u1ebf b\u00e0o B (CLL) kh\u00f4ng s\u1ea3n xu\u1ea5t \u0111\u1ee7 kh\u00e1ng th\u1ec3 ch\u1ee9c n\u0103ng (nh\u01b0 IgG) v\u00e0 b\u1ecb h\u1ea1 gammaglobulin m\u00e1u th\u1ee9 ph\u00e1t. \u0110i\u1ec1u n\u00e0y khi\u1ebfn h\u1ecd d\u1ec5 b\u1ecb nhi\u1ec5m tr\u00f9ng xoang ho\u1eb7c ph\u1ed5i t\u00e1i ph\u00e1t.&nbsp;<\/p>\n\n\n\n<p>Li\u1ec7u ph\u00e1p thay th\u1ebf IVIG c\u00f3 th\u1ec3 gi\u00fap gi\u1ea3m s\u1ed1 l\u1ea7n nhi\u1ec5m tr\u00f9ng t\u00e1i ph\u00e1t \u1edf b\u1ec7nh nh\u00e2n CLL t\u1ebf b\u00e0o B. V\u00ed d\u1ee5, <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19330654\/\">ph\u00e2n t\u00edch t\u1ed5ng h\u1ee3p<\/a> trong ch\u00edn th\u1eed nghi\u1ec7m cho th\u1ea5y li\u1ec7u ph\u00e1p thay th\u1ebf IVIG l\u00e0m gi\u1ea3m \u0111\u00e1ng k\u1ec3 c\u00e1c b\u1ec7nh nhi\u1ec5m tr\u00f9ng l\u1edbn \u1edf b\u1ec7nh nh\u00e2n CLL.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-does-ivig-work\"><span class=\"ez-toc-section\" id=\"How_Does_IVIG_Work\"><\/span><strong>IVIG ho\u1ea1t \u0111\u1ed9ng nh\u01b0 th\u1ebf n\u00e0o?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ivig-patient.jpg\" alt=\"Patient in chair receiving IVIG therapy\" class=\"wp-image-26401\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ivig-patient.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ivig-patient-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ivig-patient-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ivig-patient-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ivig-patient-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ivig-patient-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ivig-patient-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p>M\u1eb7c d\u00f9 c\u01a1 ch\u1ebf t\u00e1c d\u1ee5ng ch\u00ednh x\u00e1c c\u1ee7a li\u1ec7u ph\u00e1p IVIG v\u1eabn ch\u01b0a \u0111\u01b0\u1ee3c bi\u1ebft r\u00f5, nh\u01b0ng c\u00e1c nghi\u00ean c\u1ee9u cho th\u1ea5y n\u00f3 c\u00f3 t\u00e1c d\u1ee5ng ch\u1ed1ng vi\u00eam v\u00e0 t\u0103ng c\u01b0\u1eddng h\u1ec7 mi\u1ec5n d\u1ecbch. \u1ede b\u1ec7nh nh\u00e2n CLL t\u1ebf b\u00e0o B, IVIG c\u00f3 th\u1ec3 mang l\u1ea1i nh\u1eefng t\u00e1c d\u1ee5ng c\u00f3 l\u1ee3i sau:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>N\u00f3 l\u00e0m t\u0103ng m\u1ee9c \u0111\u1ed9 immunoglobulin huy\u1ebft thanh<\/strong><\/li>\n<\/ul>\n\n\n\n<p>Li\u1ec7u ph\u00e1p IVIG <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8217488\/#:~:text=Overall%2C%20our%20results%20add%20new,cells%20that%20deserves%20further%20investigation.\">l\u00e0m t\u0103ng m\u1ee9c \u0111\u1ed9 globulin mi\u1ec5n d\u1ecbch<\/a> \u1edf b\u1ec7nh nh\u00e2n CLL t\u1ebf b\u00e0o B b\u1ecb h\u1ea1 gammaglobulin m\u00e1u th\u1ee9 ph\u00e1t. \u0110i\u1ec1u n\u00e0y kh\u00f4ng ch\u1ec9 gi\u00fap b\u1ec7nh nh\u00e2n ch\u1ed1ng l\u1ea1i nhi\u1ec5m tr\u00f9ng m\u00e0 c\u00f2n l\u00e0m gi\u1ea3m t\u1ea7n su\u1ea5t v\u00e0 m\u1ee9c \u0111\u1ed9 nghi\u00eam tr\u1ecdng c\u1ee7a nhi\u1ec5m tr\u00f9ng \u1edf b\u1ec7nh nh\u00e2n CLL t\u1ebf b\u00e0o B.&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>N\u00f3 c\u00f3 t\u00e1c d\u1ee5ng ch\u1ed1ng vi\u00eam<\/strong><\/li>\n<\/ul>\n\n\n\n<p>B\u00ean c\u1ea1nh vi\u1ec7c gi\u1ea3m t\u1ea7n su\u1ea5t nhi\u1ec5m tr\u00f9ng, IVIG c\u00f2n l\u00e0m gi\u1ea3m t\u00ecnh tr\u1ea1ng vi\u00eam li\u00ean quan \u0111\u1ebfn b\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u00e3n t\u00ednh t\u1ebf b\u00e0o B.&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>N\u00f3 l\u00e0m gi\u1ea3m nguy c\u01a1 bi\u1ebfn ch\u1ee9ng t\u1ef1 mi\u1ec5n d\u1ecbch<\/strong><\/li>\n<\/ul>\n\n\n\n<p>Bi\u1ebfn ch\u1ee9ng t\u1ef1 mi\u1ec5n c\u0169ng th\u01b0\u1eddng g\u1eb7p \u1edf b\u1ec7nh nh\u00e2n CLL t\u1ebf b\u00e0o B. \u1ede m\u1ed9t s\u1ed1 b\u1ec7nh nh\u00e2n, ng\u01b0\u1eddi ta \u0111\u00e3 quan s\u00e1t th\u1ea5y t\u1ebf b\u00e0o B b\u1ea5t th\u01b0\u1eddng c\u0169ng s\u1ea3n xu\u1ea5t cytokine \u1ee9c ch\u1ebf qu\u00e1 tr\u00ecnh s\u1ea3n xu\u1ea5t h\u1ed3ng c\u1ea7u v\u00e0 ti\u1ec3u c\u1ea7u b\u00ecnh th\u01b0\u1eddng, d\u1eabn \u0111\u1ebfn thi\u1ebfu m\u00e1u tan m\u00e1u t\u1ef1 mi\u1ec5n (AIHA) v\u00e0 gi\u1ea3m ti\u1ec3u c\u1ea7u mi\u1ec5n d\u1ecbch (ITP).&nbsp;<\/p>\n\n\n\n<p><a href=\"https:\/\/ameripharmaspecialty.com\/vi\/conditions-treatments\/immune-globulin-ig\/\">Li\u1ec7u ph\u00e1p IVIG<\/a> c\u00f3 th\u1ec3 gi\u00fap <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5420315\/#:~:text=Additionally%2C%20CLL%20cells%20produce%20several,development%20of%20AIHA%20and%20ITP.\">gi\u1ea3m nguy c\u01a1 thi\u1ebfu m\u00e1u tan m\u00e1u (AIHA) v\u00e0 gi\u1ea3m ti\u1ec3u c\u1ea7u mi\u1ec5n d\u1ecbch (ITP) \u1edf b\u1ec7nh nh\u00e2n CLL t\u1ebf b\u00e0o B<\/a>.<\/p>\n\n\n\n<p>&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-fdb1d2c84126ddb4145f0ce5fdd1af5e\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tNh\u1eadn \u0111\u01b0\u1ee3c s\u1ef1 cho ph\u00e9p tr\u01b0\u1edbc c\u1ee7a IVIG\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">L\u00ean l\u1ecbch t\u01b0 v\u1ea5n<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-is-there-any-specific-brand-of-ivig-available-for-b-cell-chronic-lymphocytic-leukemia-cll-patients\"><span class=\"ez-toc-section\" id=\"Is_There_Any_Specific_Brand_of_IVIG_Available_for_B-Cell_Chronic_Lymphocytic_Leukemia_CLL_Patients\"><\/span><strong>C\u00f3 lo\u1ea1i IVIG n\u00e0o d\u00e0nh ri\u00eang cho b\u1ec7nh nh\u00e2n m\u1eafc b\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u00e3n t\u00ednh t\u1ebf b\u00e0o B (CLL) kh\u00f4ng?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>C\u00f3, sau \u0111\u00e2y l\u00e0 m\u1ed9t s\u1ed1 nh\u00e3n hi\u1ec7u IVIG c\u1ee5 th\u1ec3 \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng \u0111\u1ec3 \u0111i\u1ec1u tr\u1ecb b\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u00e3n t\u00ednh t\u1ebf b\u00e0o B:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Th\u1ebb nh\u1edb Gammagard<\/li>\n\n\n\n<li><a href=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/immune-globulin-panzyga\/\">Panzyga<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/bivigam-uses-side-effects-cost-and-more\/\">Bivigam<\/a><\/li>\n\n\n\n<li>Carimune<\/li>\n<\/ul>\n\n\n\n<p>C\u00e1c lo\u1ea1i thu\u1ed1c IVIG n\u00e0y c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng ri\u00eang l\u1ebb ho\u1eb7c k\u1ebft h\u1ee3p v\u1edbi h\u00f3a tr\u1ecb li\u1ec7u \u0111\u1ec3 \u0111i\u1ec1u tr\u1ecb b\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u1ea1n t\u00ednh t\u1ebf b\u00e0o B. H\u01a1n n\u1eefa, li\u1ec1u l\u01b0\u1ee3ng v\u00e0 n\u1ed3ng \u0111\u1ed9 c\u1ee7a m\u1ed7i lo\u1ea1i IVIG kh\u00e1c nhau. B\u1ea1n c\u00f3 th\u1ec3 tham kh\u1ea3o \u00fd ki\u1ebfn b\u00e1c s\u0129 v\u00e0 nh\u1eadn \u0111\u01a1n thu\u1ed1c d\u1ef1a tr\u00ean t\u00ecnh tr\u1ea1ng b\u1ec7nh c\u1ee7a m\u00ecnh.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-do-all-b-cell-chronic-lymphocytic-leukemia-cll-patients-require-ivig-therapy\"><span class=\"ez-toc-section\" id=\"Do_All_B-Cell_Chronic_Lymphocytic_Leukemia_CLL_Patients_Require_IVIG_Therapy\"><\/span><strong>C\u00f3 ph\u1ea3i t\u1ea5t c\u1ea3 b\u1ec7nh nh\u00e2n m\u1eafc b\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u00e3n t\u00ednh t\u1ebf b\u00e0o B (CLL) \u0111\u1ec1u c\u1ea7n \u0111i\u1ec1u tr\u1ecb b\u1eb1ng IVIG kh\u00f4ng?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Kh\u00f4ng, kh\u00f4ng ph\u1ea3i t\u1ea5t c\u1ea3 b\u1ec7nh nh\u00e2n B\u1ea1ch c\u1ea7u lymphocytic m\u1ea1n t\u00ednh t\u1ebf b\u00e0o B \u0111\u1ec1u c\u1ea7n li\u1ec7u ph\u00e1p thay th\u1ebf IVIG. Li\u1ec7u ph\u00e1p n\u00e0y ch\u1ec9 \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh n\u1ebfu b\u1ec7nh nh\u00e2n c\u00f3 n\u1ed3ng \u0111\u1ed9 immunoglobulin huy\u1ebft thanh th\u1ea5p (IgG &lt; 600 mg\/dl) ho\u1eb7c c\u00f3 ti\u1ec1n s\u1eed nhi\u1ec5m tr\u00f9ng n\u1eb7ng \u00edt nh\u1ea5t m\u1ed9t l\u1ea7n trong 6 th\u00e1ng.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-summary\"><span class=\"ez-toc-section\" id=\"Summary\"><\/span><strong>B\u1ea3n t\u00f3m t\u1eaft<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>IVIG l\u00e0 m\u1ed9t li\u1ec7u ph\u00e1p hi\u1ec7u qu\u1ea3 c\u00f3 th\u1ec3 gi\u00fap ki\u1ec3m so\u00e1t m\u1ed9t s\u1ed1 bi\u1ebfn ch\u1ee9ng li\u00ean quan \u0111\u1ebfn b\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u1ea1n t\u00ednh t\u1ebf b\u00e0o B. Thu\u1ed1c n\u00e0y l\u00e0m t\u0103ng n\u1ed3ng \u0111\u1ed9 kh\u00e1ng th\u1ec3 trong huy\u1ebft thanh v\u00e0 gi\u1ea3m nguy c\u01a1 nhi\u1ec5m tr\u00f9ng t\u00e1i ph\u00e1t v\u00e0 c\u00e1c b\u1ec7nh t\u1ef1 mi\u1ec5n nh\u01b0 thi\u1ebfu m\u00e1u tan m\u00e1u (AIHA) v\u00e0 gi\u1ea3m ti\u1ec3u c\u1ea7u mi\u1ec5n d\u1ecbch (ITP) \u1edf b\u1ec7nh nh\u00e2n b\u1ea1ch c\u1ea7u lymphocytic m\u1ea1n t\u00ednh t\u1ebf b\u00e0o B.<\/p>","protected":false},"excerpt":{"rendered":"<p>Li\u1ec7u ph\u00e1p thay th\u1ebf globulin mi\u1ec5n d\u1ecbch ti\u00eam t\u0129nh m\u1ea1ch (IVIG) l\u00e0 m\u1ed9t bi\u1ec7n ph\u00e1p h\u1ed7 tr\u1ee3 m\u00e0 m\u1ed9t s\u1ed1 b\u00e1c s\u0129 k\u00ea \u0111\u01a1n cho b\u1ec7nh nh\u00e2n m\u1eafc b\u1ec7nh b\u1ea1ch c\u1ea7u lymphocytic m\u1ea1n t\u00ednh t\u1ebf b\u00e0o B (CLL) khi h\u1ecd b\u1ecb gi\u1ea3m globulin mi\u1ec5n d\u1ecbch (n\u1ed3ng \u0111\u1ed9 huy\u1ebft thanh th\u1ea5p c\u1ee7a t\u1ea5t c\u1ea3 c\u00e1c kh\u00e1ng th\u1ec3, ch\u1eb3ng h\u1ea1n nh\u01b0 IgG, IgM v\u00e0 IgA) ho\u1eb7c c\u00f3 nguy c\u01a1 cao b\u1ecb nhi\u1ec5m tr\u00f9ng t\u00e1i ph\u00e1t th\u01b0\u1eddng xuy\u00ean.\u00a0<\/p>","protected":false},"author":25,"featured_media":26400,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[7],"tags":[31],"class_list":["post-26398","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ivig","tag-dr-mark-alfonso"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IVIG for B-Cell Chronic Lymphocytic Leukemia (CLL) - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Learn about IVIG for B-cell chronic lymphocytic leukemia. Topics include the role of IVIG, how it works, recommended IVIG brands, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/\" \/>\n<meta property=\"og:locale\" content=\"vi_VN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IVIG for B-Cell Chronic Lymphocytic Leukemia (CLL) - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Learn about IVIG for B-cell chronic lymphocytic leukemia. Topics include the role of IVIG, how it works, recommended IVIG brands, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-12T22:03:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-04T22:44:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Mark Alfonso, PharmD, BCMTMS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Mark Alfonso, PharmD, BCMTMS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 ph\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\\\/\"},\"author\":{\"name\":\"Dr. Mark Alfonso, PharmD, BCMTMS\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/91fbbfa457730010998bc804c0467310\"},\"headline\":\"IVIG for B-Cell Chronic Lymphocytic Leukemia (CLL)\",\"datePublished\":\"2024-08-12T22:03:17+00:00\",\"dateModified\":\"2025-06-04T22:44:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\\\/\"},\"wordCount\":744,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/cll-patient.jpg\",\"keywords\":[\"Dr. Mark Alfonso\"],\"articleSection\":[\"IVIG\"],\"inLanguage\":\"vi\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\\\/\",\"name\":\"IVIG for B-Cell Chronic Lymphocytic Leukemia (CLL) - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/cll-patient.jpg\",\"datePublished\":\"2024-08-12T22:03:17+00:00\",\"dateModified\":\"2025-06-04T22:44:49+00:00\",\"description\":\"Learn about IVIG for B-cell chronic lymphocytic leukemia. Topics include the role of IVIG, how it works, recommended IVIG brands, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\\\/#breadcrumb\"},\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/cll-patient.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/cll-patient.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Patient with B-cell chronic lymphocytic leukemia (CLL)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IVIG for B-Cell Chronic Lymphocytic Leukemia (CLL)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vi\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/91fbbfa457730010998bc804c0467310\",\"name\":\"Dr. Mark Alfonso, PharmD, BCMTMS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"caption\":\"Dr. Mark Alfonso, PharmD, BCMTMS\"},\"description\":\"Dr. Mark Alfonso, PharmD was born and raised in Pueblo, CO. He received his pharmacy degree from the University of Colorado School of Pharmacy at the Anschutz Medical Campus in 2010. He was board certified in medication therapy management in 2022. The most rewarding part of his job is helping to answer patient questions and concerns. His areas of expertise are community pharmacy and medication therapy management. In his free time, he enjoys reading and running.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/author\\\/mark-alfonso\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IVIG for B-Cell Chronic Lymphocytic Leukemia (CLL) - AmeriPharma\u00ae Specialty Care","description":"Learn about IVIG for B-cell chronic lymphocytic leukemia. Topics include the role of IVIG, how it works, recommended IVIG brands, and more.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/","og_locale":"vi_VN","og_type":"article","og_title":"IVIG for B-Cell Chronic Lymphocytic Leukemia (CLL) - AmeriPharma\u00ae Specialty Care","og_description":"Learn about IVIG for B-cell chronic lymphocytic leukemia. Topics include the role of IVIG, how it works, recommended IVIG brands, and more.","og_url":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2024-08-12T22:03:17+00:00","article_modified_time":"2025-06-04T22:44:49+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient.jpg","type":"image\/jpeg"}],"author":"Dr. Mark Alfonso, PharmD, BCMTMS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Mark Alfonso, PharmD, BCMTMS","Est. reading time":"4 ph\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/"},"author":{"name":"Dr. Mark Alfonso, PharmD, BCMTMS","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/91fbbfa457730010998bc804c0467310"},"headline":"IVIG for B-Cell Chronic Lymphocytic Leukemia (CLL)","datePublished":"2024-08-12T22:03:17+00:00","dateModified":"2025-06-04T22:44:49+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/"},"wordCount":744,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient.jpg","keywords":["Dr. Mark Alfonso"],"articleSection":["IVIG"],"inLanguage":"vi"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/","url":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/","name":"IVIG for B-Cell Chronic Lymphocytic Leukemia (CLL) - AmeriPharma\u00ae Specialty Care","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient.jpg","datePublished":"2024-08-12T22:03:17+00:00","dateModified":"2025-06-04T22:44:49+00:00","description":"Learn about IVIG for B-cell chronic lymphocytic leukemia. Topics include the role of IVIG, how it works, recommended IVIG brands, and more.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/#breadcrumb"},"inLanguage":"vi","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/"]}]},{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient.jpg","width":1280,"height":853,"caption":"Patient with B-cell chronic lymphocytic leukemia (CLL)"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-b-cell-chronic-lymphocytic-leukemia-cll\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/zh\/"},{"@type":"ListItem","position":2,"name":"IVIG for B-Cell Chronic Lymphocytic Leukemia (CLL)"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/es\/#website","url":"https:\/\/ameripharmaspecialty.com\/es\/","name":"Ch\u0103m s\u00f3c \u0111\u1eb7c bi\u1ec7t AmeriPharma\u00ae","description":"Ch\u0103m s\u00f3c \u0111\u1eb7c bi\u1ec7t c\u1ee7a AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vi"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization","name":"Ch\u0103m s\u00f3c \u0111\u1eb7c bi\u1ec7t Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/91fbbfa457730010998bc804c0467310","name":"Ti\u1ebfn s\u0129 Mark Alfonso, D\u01b0\u1ee3c s\u0129, BCMTMS","image":{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","caption":"Dr. Mark Alfonso, PharmD, BCMTMS"},"description":"Ti\u1ebfn s\u0129 Mark Alfonso, PharmD sinh ra v\u00e0 l\u1edbn l\u00ean t\u1ea1i Pueblo, CO. \u00d4ng nh\u1eadn b\u1eb1ng d\u01b0\u1ee3c s\u0129 t\u1eeb Khoa D\u01b0\u1ee3c c\u1ee7a \u0110\u1ea1i h\u1ecdc Colorado t\u1ea1i C\u01a1 s\u1edf Y khoa Anschutz v\u00e0o n\u0103m 2010. \u00d4ng \u0111\u01b0\u1ee3c c\u1ea5p ch\u1ee9ng ch\u1ec9 qu\u1ea3n l\u00fd li\u1ec7u ph\u00e1p thu\u1ed1c v\u00e0o n\u0103m 2022. Ph\u1ea7n b\u1ed5 \u00edch nh\u1ea5t trong c\u00f4ng vi\u1ec7c c\u1ee7a \u00f4ng l\u00e0 gi\u00fap tr\u1ea3 l\u1eddi c\u00e1c c\u00e2u h\u1ecfi v\u00e0 m\u1ed1i quan t\u00e2m c\u1ee7a b\u1ec7nh nh\u00e2n. C\u00e1c l\u0129nh v\u1ef1c chuy\u00ean m\u00f4n c\u1ee7a \u00f4ng l\u00e0 qu\u1ea3n l\u00fd d\u01b0\u1ee3c ph\u1ea9m c\u1ed9ng \u0111\u1ed3ng v\u00e0 li\u1ec7u ph\u00e1p thu\u1ed1c. Trong th\u1eddi gian r\u1ea3nh r\u1ed7i, \u00f4ng th\u00edch \u0111\u1ecdc s\u00e1ch v\u00e0 ch\u1ea1y b\u1ed9.","url":"https:\/\/ameripharmaspecialty.com\/vi\/author\/mark-alfonso\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Mark Alfonso, PharmD, BCMTMS","author_link":"https:\/\/ameripharmaspecialty.com\/vi\/author\/mark-alfonso\/"},"uagb_comment_info":0,"uagb_excerpt":"Intravenous immune globulin (IVIG) replacement therapy is a supportive measure that some doctors prescribe to B-cell chronic lymphocytic leukemia (CLL) patients when they have hypogammaglobulinemia (low serum levels of all antibodies, such as IgG, IgM, and IgA) or are at a high risk of frequent recurrent infections.\u00a0","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cll-patient.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Mark Alfonso, PharmD, BCMTMS","author_link":"https:\/\/ameripharmaspecialty.com\/vi\/author\/mark-alfonso\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/vi\/category\/ivig\/\" rel=\"category tag\">IVIG<\/a>","rttpg_excerpt":"Intravenous immune globulin (IVIG) replacement therapy is a supportive measure that some doctors prescribe to B-cell chronic lymphocytic leukemia (CLL) patients when they have hypogammaglobulinemia (low serum levels of all antibodies, such as IgG, IgM, and IgA) or are at a high risk of frequent recurrent infections.\u00a0","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/posts\/26398","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/comments?post=26398"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/posts\/26398\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/media\/26400"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/media?parent=26398"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/categories?post=26398"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/tags?post=26398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}